drugset / Trial / NCT01684683

The Effect of Theophylline in the Treatment of Bronchiectasis

NCT01684683

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Theophylline was well recommended in the treatment of chronic obstructive pulmonary disease (COPD) and asthma. However, there is no supporting evidence for their efficacy in the treatment of bronchiectasis. Our hypothesis is that theophylline will play a role in bronchiectasis. Our purpose is to examine the efficacy and safety of 24 weeks treatment with theophylline in subjects with non-cystic fibrosis bronchiectasis.

Timeline

Start
2012-11
Primary completion
2014-04
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Theophylline Small molecule 100 mg Oral

Indications